Enzon Pharmaceuticals Inc (OTCMKTS:ENZN)’s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.24 and traded as high as $0.26. Enzon Pharmaceuticals shares last traded at $0.26, with a volume of 8,242 shares changing hands.
The stock’s 50-day moving average is $0.24.
About Enzon Pharmaceuticals (OTCMKTS:ENZN)
Enzon Pharmaceuticals, Inc, together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Recommended Story: SEC Filing
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.